{
  "model": "gpt-4o",
  "prompt_version": "v1",
  "prompt_name": "Basic sentence generation",
  "timestamp": "2026-01-19T20:53:17.830440",
  "per_article_results": [
    {
      "pmcid": "PMC5508045",
      "variants": [
        {
          "variant": "rs9923231",
          "generated": "The variant rs9923231 (VKORC1 \u2212 1639G > A) is associated with a significantly lower stable weekly dose of warfarin in Thai patients as compared to the wild-type GG genotype.",
          "ground_truth": [
            "Genotypes CT + TT are associated with decreased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism or Venous Thrombosis as compared to genotype CC."
          ],
          "best_similarity": 0.2222222222222222,
          "best_match_idx": 0,
          "best_match": "Genotypes CT + TT are associated with decreased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism or Venous Thrombosis as compared to genotype CC.",
          "all_similarities": [
            0.2222222222222222
          ]
        },
        {
          "variant": "rs1057910",
          "generated": "Genotype CYP2C9*3/*3 is associated with a significantly lower stable weekly dose of warfarin in Thai patients as compared to genotype CYP2C9*1/*1.",
          "ground_truth": [
            "Genotypes AC + CC are associated with decreased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to genotype AA."
          ],
          "best_similarity": 0.2564102564102564,
          "best_match_idx": 0,
          "best_match": "Genotypes AC + CC are associated with decreased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to genotype AA.",
          "all_similarities": [
            0.2564102564102564
          ]
        },
        {
          "variant": "rs2108622",
          "generated": "The CYP4F2 rs2108622 TT genotype is associated with a modest increase in warfarin dose requirements in Thai patients as compared to the CC genotype.",
          "ground_truth": [
            "Genotype TT is associated with increased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to genotype CC."
          ],
          "best_similarity": 0.34285714285714286,
          "best_match_idx": 0,
          "best_match": "Genotype TT is associated with increased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to genotype CC.",
          "all_similarities": [
            0.34285714285714286
          ]
        },
        {
          "variant": "rs887829",
          "generated": "The UGT1A1 rs887829 polymorphism is not associated with variability in stable warfarin doses when treated with warfarin in Thai patients as compared to wild-type allele carriers.",
          "ground_truth": [
            "Allele C is not associated with dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to allele T."
          ],
          "best_similarity": 0.2564102564102564,
          "best_match_idx": 0,
          "best_match": "Allele C is not associated with dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to allele T.",
          "all_similarities": [
            0.2564102564102564
          ]
        }
      ],
      "avg_similarity": 0.26947496947496946
    },
    {
      "pmcid": "PMC554812",
      "variants": [
        {
          "variant": "HLA-B*58:01",
          "generated": "HLA-B*58:01 is associated with severe cutaneous adverse reactions when treated with allopurinol in Han Chinese as compared to allopurinol-tolerant individuals and healthy subjects.",
          "ground_truth": [
            "HLA-B *58:01 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol."
          ],
          "best_similarity": 0.37037037037037035,
          "best_match_idx": 0,
          "best_match": "HLA-B *58:01 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol.",
          "all_similarities": [
            0.37037037037037035
          ]
        },
        {
          "variant": "HLA-DRB1*03:01",
          "generated": "HLA-DRB1*03:01 is associated with an increased risk of severe cutaneous adverse reactions when treated with allopurinol in Han Chinese as compared to allopurinol-tolerant individuals.",
          "ground_truth": [
            "HLA-DRB1 *03:01 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol."
          ],
          "best_similarity": 0.52,
          "best_match_idx": 0,
          "best_match": "HLA-DRB1 *03:01 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol.",
          "all_similarities": [
            0.52
          ]
        },
        {
          "variant": "HLA-C*03:02",
          "generated": "HLA-C*03:02 is associated with an increased risk of severe cutaneous adverse reactions when treated with allopurinol in Han Chinese as compared to allopurinol-tolerant individuals.",
          "ground_truth": [
            "HLA-C *03:02 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol."
          ],
          "best_similarity": 0.52,
          "best_match_idx": 0,
          "best_match": "HLA-C *03:02 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol.",
          "all_similarities": [
            0.52
          ]
        },
        {
          "variant": "HLA-A*33:03",
          "generated": "HLA-A*33:03 is associated with an increased risk of severe cutaneous adverse reactions when treated with allopurinol in Han Chinese as compared to the general population.",
          "ground_truth": [
            "HLA-A *33:03 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol."
          ],
          "best_similarity": 0.5,
          "best_match_idx": 0,
          "best_match": "HLA-A *33:03 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol.",
          "all_similarities": [
            0.5
          ]
        },
        {
          "variant": "rs1594",
          "generated": "The variant rs1594 is not associated with allopurinol-induced severe cutaneous adverse reactions (SCAR) in Han Chinese as compared to allopurinol-tolerant controls.",
          "ground_truth": [
            "Allele A is associated with severe cutaneous adverse reactions when treated with allopurinol as compared to allele G."
          ],
          "best_similarity": 0.37037037037037035,
          "best_match_idx": 0,
          "best_match": "Allele A is associated with severe cutaneous adverse reactions when treated with allopurinol as compared to allele G.",
          "all_similarities": [
            0.37037037037037035
          ]
        }
      ],
      "avg_similarity": 0.4561481481481481
    }
  ],
  "avg_similarity": 0.3731822909600687,
  "total_variants": 9
}